256 related articles for article (PubMed ID: 4604198)
21. Subjective effects of narcotic antagonists cyclazocine and nalorphine on the Addiction Research Center Inventory (ARCI).
Haertzen CA
Psychopharmacologia; 1970; 18(4):366-77. PubMed ID: 4923522
[No Abstract] [Full Text] [Related]
22. Narcotic antagonists in the treatment of opiate dependence.
Fink M; Zaks A; Resnick RB; Freedman AM
Int Z Klin Pharmakol Ther Toxikol; 1971 Jun; 4(4):455-8. PubMed ID: 5566728
[No Abstract] [Full Text] [Related]
23. Narcotic-antagonist assay procedures in dogs.
Dewey WL
Adv Biochem Psychopharmacol; 1973; 8(0):263-72. PubMed ID: 4794991
[No Abstract] [Full Text] [Related]
24. The effects of morphine and nalorphine-like drugs in the nondependent, morphine-dependent and cyclazocine-dependent chronic spinal dog.
Gilbert PE; Martin WR
J Pharmacol Exp Ther; 1976 Jul; 198(1):66-82. PubMed ID: 945350
[TBL] [Abstract][Full Text] [Related]
25. Agonistic properties of narcotic analgesics and antagonists on the electroencephalogram and behavior in the rat and their reversal by naloxone.
Colasanti B; Khazan N
Neuropharmacology; 1973 Jul; 12(7):619-27. PubMed ID: 4730371
[No Abstract] [Full Text] [Related]
26. Inhibition of writhing by narcotic antagonists.
Pearl J; Harris LS
J Pharmacol Exp Ther; 1966 Nov; 154(2):319-23. PubMed ID: 4380744
[No Abstract] [Full Text] [Related]
27. Drug action on tail shock-induced vocalization in mice and its relevance to analgesia.
Weller CP; Sulman FG
Eur J Pharmacol; 1970 Feb; 9(2):227-34. PubMed ID: 5437157
[No Abstract] [Full Text] [Related]
28. Opiate antagonists and 'blockers'.
Murphree HB
Am Fam Physician; 1973 Apr; 7(4):136-7. PubMed ID: 4694336
[No Abstract] [Full Text] [Related]
29. The use of primates in screening dependence liability.
Swain HH
Pharmacol Ther B; 1979; 5(1-3):519-22. PubMed ID: 115019
[No Abstract] [Full Text] [Related]
30. Assays for narcotic antagonist activity in rodents.
Pierson AK
Adv Biochem Psychopharmacol; 1973; 8(0):245-61. PubMed ID: 4152786
[No Abstract] [Full Text] [Related]
31. Arylpyrrolidines as narcotic antagonists.
McCarthy DA
Adv Biochem Psychopharmacol; 1973; 8(0):145-55. PubMed ID: 4211813
[No Abstract] [Full Text] [Related]
32. Sites of action of morphine involved in the development of physical dependence in rats. I. Comparison of precipitated morphine withdrawal after intraperitoneal and intraventricular injection of morphine antagonists.
Laschka E; Herz A; Bläsig J
Psychopharmacologia; 1976 Mar; 46(2):133-9. PubMed ID: 986051
[TBL] [Abstract][Full Text] [Related]
33. Requirements for extinction of relapse-facilitating variables and for rehabilitation in a narcotic-antagonist treatment program.
Wikler A
Adv Biochem Psychopharmacol; 1973; 8(0):399-414. PubMed ID: 4795072
[No Abstract] [Full Text] [Related]
34. Effects of narcotic analgesic agonists and antagonists on rat brain acetylcholine.
Domino EF; Wilson A
J Pharmacol Exp Ther; 1973 Jan; 184(1):18-32. PubMed ID: 4734420
[No Abstract] [Full Text] [Related]
35. Behavioural effects of some morphine antagonists and hallucinogens in the rat.
Schneider C
Nature; 1968 Nov; 220(5167):586-7. PubMed ID: 5686733
[No Abstract] [Full Text] [Related]
36. Pharmacological approaches to the treatment of morphine-type dependence.
Halbach H
Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):6-12. PubMed ID: 1165143
[TBL] [Abstract][Full Text] [Related]
37. Discrimination of a single dose of morphine followed by naltrexone: substitution of other agonists for morphine and other antagonists for naltrexone in a rat model of acute dependence.
Holtzman SG
J Pharmacol Exp Ther; 2003 Mar; 304(3):1033-41. PubMed ID: 12604679
[TBL] [Abstract][Full Text] [Related]
38. Opiate physical dependence and N-methyl-D-aspartate receptors.
Noda Y; Nabeshima T
Eur J Pharmacol; 2004 Oct; 500(1-3):121-8. PubMed ID: 15464026
[TBL] [Abstract][Full Text] [Related]
39. [The effect of GABA-positive agents on the formation of morphine dependence and on the manifestations of a withdrawal syndrome].
Belozertseva IV; Andreev BV
Eksp Klin Farmakol; 2000; 63(1):19-23. PubMed ID: 10763104
[TBL] [Abstract][Full Text] [Related]
40. Plasma malondialdehyde levels and opiate withdrawal signs observed in rats treated with morphine plus naloxone: effects of alpha-lipoic acid administration.
Pinelli A; Cighetti G; Trivulzio S
Fundam Clin Pharmacol; 2008 Aug; 22(4):439-45. PubMed ID: 18705754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
